Skip to main content
letter
. 2021 Nov 10:zwab175. doi: 10.1093/eurjpc/zwab175

Table 1.

Baseline characteristics of heart transplant patients infected with COVID-19

Study Total cases of HT Median age (years) Male, n (%) Median time since transplant (years) Diabetes, n (%) Hyper tension, n (%) CKD, n (%) Mortality, n (%) Hospitali zation, n (%) ICU admission, n (%) Invasive ventilation, n (%)
Bottio et al. (Cohort 1) 47 61.84 37 (79) 10.46 ± 8.70a 8 (17) 30 (64) NA 14 (37) 38 (81) 4 (9) 2 (4)
Bottio et al. (Cohort 2) 6 59 4 (67) 7.8a 2 (33) 4 (67) NA 6 (100) 1 (17) 0 (0) 0 (0)
Coll et al. 69 64 54 (79) 10.17 NA NA NA 13 (22) 51 (86) 7 (12) 3 (6)
Singhvi et al. 22 58.6 14 (63.6) 4.6 12 (54.5) 21 (95.5) 14 (63.6) 5 (22.7%) 19 (86.4) 4 (18.2) 4 (21.1)
Trapani et al. 53 59.8a NA 6.1 NA NA NA 19 (35.8) NA NA NA
García-Cosío et al. 13 63 10 (76.9) 17 2 (15.4) 7 (53.8) 6 (46.2) 4 (31) 11 (84.6) 1 (8.3) 1 (8.3)
Felldin et al. 6 55a 5 (83.3) 11.7 1(16.7) 2 (33.3) 2 (33.3) 1 (16.7) 3 (50) NA NA
Rivinius et al. 21 58.6 17 (81.0) 7.83 ± 6.89a 7 (33.3) 15 (71.4) 6 (28.6) 7 (33.3) 19 (90.5) 17 (71.4) 8 (38.1)
Ketcham et al. 13 61a 13 (100) 8 9 (69) 11 (85) 11 (85) 2(15) 13 (100) 13 (46) 5/13 (38)
Latif et al. 28 64 22 (79) 8.6 17 (61) 20 (71) 10 (36) 7 (25) 22 (79) 7 (25) 7 (25)
Sharma et al. 10 NA NA NA NA NA NA 3 (33.3) NA NA NA
Hoek et al. 4 51 3 (100) 10 NA NA NA 0 (0) NA NA NA
Fiocco et al. 6 NA NA NA NA NA NA 2 (33.3) NA NA NA
Ahluwalia et al. 5 50 4 (80) 21 5 (100) 5 (100) 5 (100) 1 (20) 3 (60) NA NA
Marcondes- Braga et al. 40 53 24 (60) 2.8 10 (25) 14 (35) 15 (37.5) 11 (27.5) 33 (82.5) 17 (42.5) 9 (22.5)
Granger et al. 39 54.4 26 (66.7) 4.9 16 (40) 28 (71.8) 21 (53.8) 10 (25.6) 35 (89.7) 14 (35.9) 8 (20.5)
Simonenko et al. 12 NA NA NA NA NA NA NA NA NA NA
Ravanan et al. 23 NA NA NA NA NA NA 6 (26.1) NA NA NA
Carey et al. 8 NA NA NA NA NA NA NA NA NA NA

CKD, chronic kidney disease; HT, heart transplant; NA, not available.

a

Mean.